Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ACO2 pseudogene 1 (ACO2P1) is a human pseudogene located on chromosome 22q13.31 (GRCh38/hg38: chr22:34589085-34591278). It exhibits sequence similarity to the functional Aconitase 2, mitochondrial (ACO2), an enzyme vital for mitochondrial energy metabolism in the TCA cycle. However, ACO2P1 is a non-coding genomic element classified as a pseudogene, meaning it lacks protein-coding capacity and does not produce a functional protein. Consequently, it has no confirmed biological or disease role, drug interaction, or utility as a therapeutic target. There is no evidence for therapeutic or biomarker relevance; it is not involved in disease mechanisms, drug interaction, or patient stratification. ACO2P1 is not considered a therapeutic target; it is a fossil genetic element derived from a once-functional gene that has lost its protein-coding function. Its clinical and functional significance remains unknown at this time. Standard sources (GeneCards, BioGPS) confirm ACO2P1 as a pseudogene without functional annotation[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aconitase 2 pseudogene 1 (ACO2P1).